Top

Cancer Causes & Control

Published in:

01-08-2012 | Original paper

Cancer in childhood, adolescence, and young adults: a population-based study of changes in risk of cancer death during four decades in Norway

Authors: Sara Ghaderi, Rolv Terje Lie, Dag Moster, Ellen Ruud, Astri Syse, Finn Wesenberg, Tone Bjørge

Published in: Cancer Causes & Control | Issue 8/2012

Abstract

Purpose

Cancer is one of the most common causes of death among young individuals. The purpose of this study was to explore the risk of early death (the first five years after diagnosis) among children (0–14 years), adolescents (15–19 years), and young adults (20–24 years) with cancer in Norway, born during 1965–1985.

Methods

The overall and cancer-specific early deaths were explored by linking population-based national registers (including the Cancer Registry of Norway and the Cause of Death Registry) that include the entire population of Norway (approximately 1.3 million individuals). Hazard and sub-hazard ratios were estimated using Cox regression analyses and competing risk models.

Results

A total of 5,828 individuals were diagnosed with cancer (56.3 % males). During follow-up, 1,415 individuals died from cancer (60.2 % males) within five years after diagnosis. The hazard ratio (HR) of overall death of the cancer patients relative to the general population decreased from 1965 (from HR, 385.8 (95 % confidence interval (CI): 335.3, 443.4) in 1965-74 to HR, 19.7 (CI: 9.3, 41.5) in 2005-09). Over all, there were fewer cancer-related deaths among female compared with male patients (sub-hazard ratio (SHR), 0.83 (CI: 0.74, 0.92)). Except for all hematopoietic malignancies, adolescents and young adult patients had lower risk of cancer death than children.

Conclusion

The difference in risk of cancer and overall deaths between the cancer patients and the general population has been substantially reduced since 1965.

Gonzalez JR, Fernandez E, de Toledo JS et al (2004) Trends in childhood cancer incidence and mortality in Catalonia, Spain, 1975–1998. Eur J Cancer Prev 13(1):47–51PubMedCrossRef

Bosetti C, Bertuccio P, Chatenoud L, Negri E, Levi F, La VC (2010) Childhood cancer mortality in Europe, 1970–2007. Eur J Cancer 46(2):384–394PubMedCrossRef

Lawless SC, Verma P, Green DM, Mahoney MC (2007) Mortality experiences among 15+ year survivors of childhood and adolescent cancers. Pediatr Blood Cancer 48(3):333–338PubMedCrossRef

Desandes E (2007) Survival from adolescent cancer. Cancer Treat Rev 33(7):609–615PubMedCrossRef

Helgestad J, Madsen B (2005) Survival of children with cancer. Tidsskr Nor Laegeforen 125(18):2491–2492PubMed

Moller TR, Garwicz S, Barlow L et al (2001) Decreasing late mortality among 5-year survivors of cancer in childhood and adolescence: a population-based study in the Nordic countries. J Clin Oncol 19(13):3173–3181PubMed

Zuccolo L, Pastore G, Maule M et al (2004) Time trends of childhood cancer mortality rates: a report from the Childhood Cancer Registry of Piedmont, Italy, 1971–1998. Pediatr Blood Cancer 43(7):788–791PubMedCrossRef

Chatenoud L, Bertuccio P, Bosetti C, Levi F, Negri E, La VC (2010) Childhood cancer mortality in America, Asia, and Oceania, 1970 through 2007. Cancer 116(21):5063–5074PubMedCrossRef

Yaris N, Mandiracioglu A, Buyukpamukcu M (2004) Childhood cancer in developing countries. Pediatr Hematol Oncol 21(3):237–253PubMedCrossRef

10.

Gatta G, Capocaccia R, De AR, Stiller C, Coebergh JW (2003) Cancer survival in European adolescents and young adults. Eur J Cancer 39(18):2600–2610PubMedCrossRef

11.

NORDCAN (2009) Association of the Nordic Cancer Registries

12.

SEER (2011) National cancer institute

13.

Cancer in Norway (2008) (2009) Cancer incidence, mortality, survival and prevalence in Norway. Kreftregisteret, Oslo

14.

World Health Organization (WHO). (2011) ICD systems

15.

Larsen IK, Smastuen M, Johannesen TB et al (2009) Data quality at the Cancer Registry of Norway: an overview of comparability, completeness, validity and timeliness. Eur J Cancer 45(7):1218–1231PubMedCrossRef

16.

Health Statistics (2002) Atlas on mortality in the European Union: data 1994–1996. Office for Official Publications of the European Communities, Luxembourg

17.

Lau B, Cole SR, Gange SJ (2009) Competing risk regression models for epidemiologic data. Am J Epidemiol 170(2):244–256PubMedCrossRef

18.

Smith MA, Seibel NL, Altekruse SF et al (2010) Outcomes for children and adolescents with cancer: challenges for the twenty-first century. J Clin Oncol 28(15):2625–2634PubMedCrossRef

19.

Ward EM, Thun MJ, Hannan LM, Jemal A (2006) Interpreting cancer trends. Ann N Y Acad Sci 1076:29–53PubMedCrossRef

20.

Yang L, Fujimoto J, Qiu D, Sakamoto N (2009) Childhood cancer in Japan: focusing on trend in mortality from 1970 to 2006. Ann Oncol 20(1):166–174PubMedCrossRef

21.

Gatta G, Zigon G, Capocaccia R et al (2009) Survival of European children and young adults with cancer diagnosed 1995–2002. Eur J Cancer 45(6):992–1005PubMedCrossRef

22.

Baade PD, Youlden DR, Valery PC et al (2010) Trends in incidence of childhood cancer in Australia, 1983–2006. Br J Cancer 102(3):620–626PubMedCrossRef

23.

Gatta G, Capocaccia R, Stiller C, Kaatsch P, Berrino F, Terenziani M (2005) Childhood cancer survival trends in Europe: a EUROCARE Working Group study. J Clin Oncol 23(16):3742–3751PubMedCrossRef

24.

Kaatsch P (2010) Epidemiology of childhood cancer. Cancer Treat Rev 36(4):277–285

25.

Pui CH (1995) Childhood leukemias. N Engl J Med 332(24):1618–1630PubMedCrossRef

26.

McBride ML, Rogers PC, Sheps SB et al (2010) Childhood, adolescent, and young adult cancer survivors research program of British Columbia: objectives, study design, and cohort characteristics. Pediatr Blood Cancer 55(2):324–330PubMedCrossRef

27.

Fernandez CV, Barr RD (2006) Adolescents and young adults with cancer: an orphaned population. Paediatr Child Health 11(2):103–106PubMed

28.

Yang CP, Hung IJ, Jaing TH, Chang WH (2006) Cancers in infancy: percent distribution and incidence rates. Acta Paediatr Taiwan 47(6):273–277PubMed

29.

Tai E, Pollack LA, Townsend J, Li J, Steele CB, Richardson LC (2010) Non-Hodgkin lymphoma survival among adolescents. Arch Pediatr Adolesc Med 164(8):779–780PubMedCrossRef

30.

Hampton T (2005) Cancer treatment’s trade-off: years of added life can have long-term costs. JAMA 294(2):167–168PubMedCrossRef

31.

Armstrong GT, Liu Q, Yasui Y et al (2009) Late mortality among 5-year survivors of childhood cancer: a summary from the Childhood Cancer Survivor Study. J Clin Oncol 27(14):2328–2338PubMedCrossRef

32.

Garwicz S, Moller T, Olsen JH, Sankila R (2004) Nordic studies on late effects of treatment of cancer in childhood and adolescence. Acta Oncol 43(7):682–683

33.

Nathan PC, Greenberg ML, Ness KK et al (2008) Medical care in long-term survivors of childhood cancer: a report from the childhood cancer survivor study. J Clin Oncol 26(27):4401–4409PubMedCrossRef

34.

Shah A, Stiller CA, Kenward MG, Vincent T, Eden TO, Coleman MP (2008) Childhood leukaemia: long-term excess mortality and the proportion ‘cured’. Br J Cancer 99(1):219–223PubMedCrossRef

35.

Nathan PC, Ford JS, Henderson TO et al (2009) Health behaviors, medical care, and interventions to promote healthy living in the Childhood Cancer Survivor Study cohort. J Clin Oncol 27(14):2363–2373PubMedCrossRef

36.

Kahalley LS, Robinson LA, Tyc VL et al (2012) Risk factors for smoking among adolescent survivors of childhood cancer: A report from the childhood cancer survivor study. Pediatr Blood Cancer 58(3):428–434

37.

Reulen RC, Winter DL, Frobisher C et al (2010) Long-term cause-specific mortality among survivors of childhood cancer. JAMA 304(2):172–179PubMedCrossRef

38.

Prasad PK, Signorello LB, Friedman DL, Boice JD Jr, Pukkala E (2012) Long-term non-cancer mortality in pediatric and young adult cancer survivors in Finland. Pediatr Blood Cancer 58(3):421–427PubMedCrossRef

Title: Cancer in childhood, adolescence, and young adults: a population-based study of changes in risk of cancer death during four decades in Norway
Authors: Sara Ghaderi
Rolv Terje Lie
Dag Moster
Ellen Ruud
Astri Syse
Finn Wesenberg
Tone Bjørge
Publication date: 01-08-2012
Publisher: Springer Netherlands
Published in: Cancer Causes & Control / Issue 8/2012
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI: https://doi.org/10.1007/s10552-012-0007-x

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 8/2012

Hematologic malignancies: an opportunity to fill a gap in cancer surveillance

Serum calcium and incident and fatal prostate cancer in the Swedish AMORIS study

Comparison of breast and cervical cancer screening utilization among rural and urban Hispanic and American Indian women in the Southwestern United States

Variation in xenobiotic transport and metabolism genes, household chemical exposures, and risk of childhood acute lymphoblastic leukemia

Plasma total, LDL, and HDL cholesterol and risk of aggressive prostate cancer in the Cancer Prevention Study II Nutrition Cohort

Seasonal variation in expression of markers in the vitamin D pathway in prostate tissue

Keynote webinar | Spotlight on antibody–drug conjugates in cancer